Logo image of NU

NU HOLDINGS LTD/CAYMAN ISL-A (NU) Stock Fundamental Analysis

USA - NYSE:NU - KYG6683N1034 - Common Stock

15.87 USD
-0.07 (-0.44%)
Last: 11/7/2025, 8:04:00 PM
15.9193 USD
+0.05 (+0.31%)
After Hours: 11/7/2025, 8:04:00 PM
Fundamental Rating

5

Taking everything into account, NU scores 5 out of 10 in our fundamental rating. NU was compared to 390 industry peers in the Banks industry. While NU is still in line with the averages on profitability rating, there are concerns on its financial health. NU is growing strongly while it is still valued neutral. This is a good combination!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year NU was profitable.
NU had a positive operating cash flow in the past year.
In multiple years NU reported negative net income over the last 5 years.
Of the past 5 years NU 4 years had a positive operating cash flow.
NU Yearly Net Income VS EBIT VS OCF VS FCFNU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B -2B

1.2 Ratios

NU has a Return On Assets of 3.67%. This is amongst the best in the industry. NU outperforms 100.00% of its industry peers.
NU has a Return On Equity of 24.02%. This is amongst the best in the industry. NU outperforms 99.74% of its industry peers.
The Return On Invested Capital of NU (4.41%) is better than 100.00% of its industry peers.
Industry RankSector Rank
ROA 3.67%
ROE 24.02%
ROIC 4.41%
ROA(3y)1.7%
ROA(5y)0.52%
ROE(3y)11.47%
ROE(5y)-1.69%
ROIC(3y)N/A
ROIC(5y)N/A
NU Yearly ROA, ROE, ROICNU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 20 -20

1.3 Margins

NU has a worse Profit Margin (17.90%) than 70.00% of its industry peers.
The Operating Margin of NU (24.65%) is better than 98.72% of its industry peers.
NU has a Gross Margin of 43.42%. This is amongst the best in the industry. NU outperforms 100.00% of its industry peers.
NU's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 24.65%
PM (TTM) 17.9%
GM 43.42%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.85%
GM growth 5Y2.4%
NU Yearly Profit, Operating, Gross MarginsNU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NU is destroying value.
The number of shares outstanding for NU has been increased compared to 1 year ago.
NU has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, NU has a worse debt to assets ratio.
NU Yearly Shares OutstandingNU Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B
NU Yearly Total Debt VS Total AssetsNU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.2 Solvency

Based on the Altman-Z score of 0.54, we must say that NU is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.54, NU belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
The Debt to FCF ratio of NU is 10.94, which is on the high side as it means it would take NU, 10.94 years of fcf income to pay off all of its debts.
NU has a Debt to FCF ratio of 10.94. This is in the lower half of the industry: NU underperforms 78.97% of its industry peers.
A Debt/Equity ratio of 4.05 is on the high side and indicates that NU has dependencies on debt financing.
NU has a worse Debt to Equity ratio (4.05) than 95.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.05
Debt/FCF 10.94
Altman-Z 0.54
ROIC/WACC0.31
WACC14.27%
NU Yearly LT Debt VS Equity VS FCFNU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B 6B

2.3 Liquidity

A Current Ratio of 0.18 indicates that NU may have some problems paying its short term obligations.
NU has a better Current ratio (0.18) than 100.00% of its industry peers.
NU has a Quick Ratio of 0.18. This is a bad value and indicates that NU is not financially healthy enough and could expect problems in meeting its short term obligations.
NU has a better Quick ratio (0.18) than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.18
Quick Ratio 0.18
NU Yearly Current Assets VS Current LiabilitesNU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

8

3. Growth

3.1 Past

NU shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 38.89%, which is quite impressive.
Looking at the last year, NU shows a very strong growth in Revenue. The Revenue has grown by 26.88%.
The Revenue has been growing by 79.85% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)38.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.67%
Revenue 1Y (TTM)26.88%
Revenue growth 3Y89.29%
Revenue growth 5Y79.85%
Sales Q2Q%28.78%

3.2 Future

Based on estimates for the next years, NU will show a very strong growth in Earnings Per Share. The EPS will grow by 38.41% on average per year.
NU is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 22.90% yearly.
EPS Next Y35.62%
EPS Next 2Y38.88%
EPS Next 3Y38.41%
EPS Next 5YN/A
Revenue Next Year21.24%
Revenue Next 2Y22.39%
Revenue Next 3Y22.9%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
NU Yearly Revenue VS EstimatesNU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5B 10B 15B 20B
NU Yearly EPS VS EstimatesNU Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.2 0.4 0.6 0.8 1

4

4. Valuation

4.1 Price/Earnings Ratio

NU is valuated quite expensively with a Price/Earnings ratio of 31.74.
Based on the Price/Earnings ratio, NU is valued more expensive than 85.13% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 25.83, NU is valued a bit more expensive.
The Price/Forward Earnings ratio is 18.28, which indicates a rather expensive current valuation of NU.
Based on the Price/Forward Earnings ratio, NU is valued a bit more expensive than 77.69% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 32.68. NU is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 31.74
Fwd PE 18.28
NU Price Earnings VS Forward Price EarningsNU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, NU is valued cheaply inside the industry as 98.72% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of NU indicates a slightly more expensive valuation: NU is more expensive than 71.03% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 20.91
EV/EBITDA 21.82
NU Per share dataNU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

NU's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
NU has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as NU's earnings are expected to grow with 38.41% in the coming years.
PEG (NY)0.89
PEG (5Y)N/A
EPS Next 2Y38.88%
EPS Next 3Y38.41%

0

5. Dividend

5.1 Amount

NU does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NU HOLDINGS LTD/CAYMAN ISL-A

NYSE:NU (11/7/2025, 8:04:00 PM)

After market: 15.9193 +0.05 (+0.31%)

15.87

-0.07 (-0.44%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)08-14 2025-08-14/amc
Earnings (Next)11-13 2025-11-13/amc
Inst Owners79.06%
Inst Owner Change-0.2%
Ins Owners0.29%
Ins Owner Change0%
Market Cap76.47B
Revenue(TTM)12.85B
Net Income(TTM)2.30B
Analysts80.83
Price Target16.73 (5.42%)
Short Float %2.87%
Short Ratio2.1
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.18%
Min EPS beat(2)-6.52%
Max EPS beat(2)4.16%
EPS beat(4)2
Avg EPS beat(4)0.28%
Min EPS beat(4)-6.52%
Max EPS beat(4)6.03%
EPS beat(8)5
Avg EPS beat(8)3.02%
EPS beat(12)9
Avg EPS beat(12)24.29%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-2.62%
Min Revenue beat(2)-5.67%
Max Revenue beat(2)0.42%
Revenue beat(4)2
Avg Revenue beat(4)-4.23%
Min Revenue beat(4)-11.83%
Max Revenue beat(4)0.42%
Revenue beat(8)5
Avg Revenue beat(8)-1.19%
Revenue beat(12)8
Avg Revenue beat(12)-0.39%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.4%
PT rev (3m)16.73%
EPS NQ rev (1m)0%
EPS NQ rev (3m)5.26%
EPS NY rev (1m)0.08%
EPS NY rev (3m)3.24%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.13%
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)-0.31%
Valuation
Industry RankSector Rank
PE 31.74
Fwd PE 18.28
P/S 5.95
P/FCF 20.91
P/OCF 19.4
P/B 7.99
P/tB 8.84
EV/EBITDA 21.82
EPS(TTM)0.5
EY3.15%
EPS(NY)0.87
Fwd EY5.47%
FCF(TTM)0.76
FCFY4.78%
OCF(TTM)0.82
OCFY5.15%
SpS2.67
BVpS1.99
TBVpS1.8
PEG (NY)0.89
PEG (5Y)N/A
Graham Number4.73
Profitability
Industry RankSector Rank
ROA 3.67%
ROE 24.02%
ROCE 27.16%
ROIC 4.41%
ROICexc 5.28%
ROICexgc 5.43%
OM 24.65%
PM (TTM) 17.9%
GM 43.42%
FCFM 28.46%
ROA(3y)1.7%
ROA(5y)0.52%
ROE(3y)11.47%
ROE(5y)-1.69%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.85%
GM growth 5Y2.4%
F-Score5
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity 4.05
Debt/FCF 10.94
Debt/EBITDA 11.92
Cap/Depr 335.54%
Cap/Sales 2.21%
Interest Coverage 51.91
Cash Conversion 121.18%
Profit Quality 159%
Current Ratio 0.18
Quick Ratio 0.18
Altman-Z 0.54
F-Score5
WACC14.27%
ROIC/WACC0.31
Cap/Depr(3y)276.52%
Cap/Depr(5y)220.29%
Cap/Sales(3y)2.04%
Cap/Sales(5y)1.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)38.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.67%
EPS Next Y35.62%
EPS Next 2Y38.88%
EPS Next 3Y38.41%
EPS Next 5YN/A
Revenue 1Y (TTM)26.88%
Revenue growth 3Y89.29%
Revenue growth 5Y79.85%
Sales Q2Q%28.78%
Revenue Next Year21.24%
Revenue Next 2Y22.39%
Revenue Next 3Y22.9%
Revenue Next 5YN/A
EBIT growth 1Y39.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year140.14%
EBIT Next 3Y40.94%
EBIT Next 5YN/A
FCF growth 1Y97.99%
FCF growth 3YN/A
FCF growth 5Y52.3%
OCF growth 1Y96.38%
OCF growth 3YN/A
OCF growth 5Y54.09%

NU HOLDINGS LTD/CAYMAN ISL-A / NU FAQ

What is the fundamental rating for NU stock?

ChartMill assigns a fundamental rating of 5 / 10 to NU.


What is the valuation status for NU stock?

ChartMill assigns a valuation rating of 4 / 10 to NU HOLDINGS LTD/CAYMAN ISL-A (NU). This can be considered as Fairly Valued.


Can you provide the profitability details for NU HOLDINGS LTD/CAYMAN ISL-A?

NU HOLDINGS LTD/CAYMAN ISL-A (NU) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for NU stock?

The Price/Earnings (PE) ratio for NU HOLDINGS LTD/CAYMAN ISL-A (NU) is 31.74 and the Price/Book (PB) ratio is 7.99.


What is the financial health of NU HOLDINGS LTD/CAYMAN ISL-A (NU) stock?

The financial health rating of NU HOLDINGS LTD/CAYMAN ISL-A (NU) is 2 / 10.